Canada Development Corporation

The Canada Development Corporation (CDC) was a Canadian corporation established to encourage the growth and maintenance of Canadian-controlled companies in the private sector. Based in Toronto, it was created in response to concerns about foreign ownership of the Canadian economy, particularly in natural resources, manufacturing, and other strategically important industries. Its institutional origins lay in Walter Gordon's Royal Commission on Canada's Economic Prospects and the 1968 Watkins Report, which examined ways to increase Canadian participation in major corporations and economic assets. The CDC occupied an unusual position between the public and private sectors. The federal government helped establish and capitalize it and remained a shareholder, but the corporation was deliberately structured not to operate as a conventional Crown corporation. It was intended to pursue profitable commercial activities, did not require Governor-in-Council approval for its ordinary business decisions, and did not report to Parliament in the same manner as a government department or Crown corporation. Parliament nevertheless defined its objects and capitalization, and changes to the objects approved by its board required parliamentary authorization. The long-term design was that government ownership would eventually decline to no more than 10 percent of the corporation's holdings, allowing the CDC to function increasingly as a market-oriented Canadian investment vehicle. The corporation raised capital from the private sector, attracting approximately 31,000 private shareholders. Its investment strategy combined direct ownership, strategic acquisitions, and government asset transfers. One early acquisition was Connaught Laboratories, a Canadian company associated with the manufacture of insulin. The CDC also built or held interests in petroleum, mining, petrochemical, and industrial businesses. Polymer Corporation, an industrial enterprise transferred to the CDC by the Canadian government, became part of this portfolio. By 1982, the corporation held a 58 percent stake in Savin Corporation, illustrating its willingness to invest beyond a narrow domestic resource portfolio. The CDC represented an interventionist approach to economic nationalism: rather than simply restricting foreign investment, it sought to build Canadian-controlled corporate capacity through a mixture of public backing and private capital. Its model reflected the policy environment of the late 1960s and 1970s, when ownership and control of Canadian resources and industry were major political and economic questions. At the same time, its hybrid governance structure exposed it to the tensions of operating commercially while carrying a national economic mandate. The corporation was dismantled in 1986 during the Progressive Conservative government of Brian Mulroney, as part of a broader privatization program. Its dissolution marked a retreat from the CDC's model of a federally supported national investment corporation and formed part of a wider shift toward privatization and reduced direct state participation in commercial ownership. The CDC is therefore significant less as a consumer-facing brand than as an important Canadian economic-policy institution and an experiment in public-private corporate development.

The Canada Development Corporation emerged from a period of concern about the extent of foreign ownership and control in the Canadian economy. Walter Gordon's Royal Commission on Canada's Economic Prospects examined the structural position of Canadian businesses and the role of foreign capital. The subsequent Watkins Report, commissioned by Gordon and issued in 1968, helped shape the policy case for a corporation capable of supporting Canadian ownership in important industries. The CDC was designed as a hybrid institution. The federal government participated in its creation and ownership, but the corporation was not technically a Crown corporation. It was expected to operate commercially and generate profits rather than function as a government department or a conventional state agency. Its ordinary activities did not require approval from the Governor-in-Council, and it was not required to report to Parliament in the same way as a Crown corporation. Parliament did, however, establish the corporation's purposes and capitalization. If the board sought to change those purposes, parliamentary approval was required. The structure was intended to combine public policy objectives with private-sector discipline. A further objective was to reduce the government's ownership over time. The CDC was conceived as a vehicle in which private investment would become increasingly important, with the expectation that the government would ultimately own no more than 10 percent of its holdings. In practice, the organization attracted roughly 31,000 private shareholders, giving it a broad private-investor base alongside its public role. The corporation made investments in sectors viewed as central to Canada's economic independence. An early acquisition was Connaught Laboratories, the original manufacturer of insulin. The CDC also held interests in petroleum, mining, petrochemicals, and industrial companies. Polymer Corporation, an industrial asset transferred to it by the Canadian government, became part of its portfolio. By 1982, the CDC had accumulated a 58 percent interest in Savin Corporation. These activities show that the CDC was not a conventional holding company focused on a single industry; it was a diversified vehicle for Canadian participation in strategic businesses. Its approach reflected the economic nationalism of the period. Rather than relying only on regulation of foreign investment, policymakers attempted to create Canadian-controlled corporate champions and preserve domestic decision-making authority in sectors such as resources and industry. The CDC therefore served both as an investor and as an instrument of national economic strategy. Its commercial mandate also meant that it had to balance profitability, shareholder interests, and the broader objective of increasing Canadian control. The model lost political support during the privatization-oriented policy shift of the 1980s. In 1986, the Mulroney government dismantled the corporation as part of its privatization program. The end of the CDC represented a significant change in the federal government's preferred role in business ownership: the state moved away from maintaining a broad public-private investment vehicle and toward divesting commercial assets. The CDC's history remains relevant to debates about economic nationalism, foreign ownership, public-private investment, and the use of state-backed corporations to develop domestic industrial capacity.

• 1986

  Corporation dismantled

  [1]Canada Development Corporationen.wikipedia.org

  The CDC was dismantled during the Mulroney government's privatization program.

• 1982

  CDC holds 58 percent of Savin Corporation

  [1]Canada Development Corporationen.wikipedia.org

  The CDC's reported 58 percent stake in Savin Corporation illustrated the breadth and scale of its investment portfolio.

• 1968

  Watkins Report commissioned

  [1]Canada Development Corporationen.wikipedia.org

  The Watkins Report, commissioned by Walter Gordon, contributed to the policy framework that led to the creation of a corporation intended to strengthen Canadian ownership of major businesses.

• Canada Development Corporation established

  [1]Canada Development Corporationen.wikipedia.org

  The CDC was created as a federally supported but commercially oriented corporation designed to develop and maintain Canadian-controlled private-sector companies.

• Private shareholder base established

  [1]Canada Development Corporationen.wikipedia.org

  Approximately 31,000 private shareholders invested in the corporation, complementing the federal government's participation.

A commercially oriented public-private vehicle for building Canadian-controlled corporate capacity in strategic industries.

• Investment portfolio

  Strategic corporate investments

  The CDC's principal offering was not a consumer product but a portfolio of equity investments and ownership positions in Canadian businesses. It targeted companies and assets in sectors considered important to national economic capacity, including natural resources, petroleum, mining, petrochemicals, and industrial manufacturing. The corporation used a combination of public capitalization and private shareholder investment to pursue these holdings.

• Healthcare and pharmaceuticals

  Connaught Laboratories

  Connaught Laboratories was one of the CDC's early acquisitions. The Canadian laboratory was historically associated with the manufacture of insulin and represented the CDC's involvement in strategically significant healthcare and biotechnology-related industrial assets.

• Industrial manufacturing and petrochemicals

  Polymer Corporation

  Polymer Corporation was an industrial enterprise transferred by the Canadian government to the CDC. Its inclusion in the portfolio reflected the corporation's role in maintaining Canadian participation in industrial and petrochemical activities.

• Industrial and office equipment

  Savin Corporation investment

  Savin Corporation was a major CDC investment. By 1982, the CDC held a reported 58 percent stake, making the company one of the clearest examples of the CDC taking a substantial controlling position in an operating business.

• 1986

  Dismantle the corporation during privatizationStrategy

  Background

  The Mulroney government pursued a broader program of privatization and a reduced direct role for the federal government in commercial ownership.

  Action taken

  The government dismantled the Canada Development Corporation.

  Aftermath

  The dissolution ended Canada's principal federally supported public-private vehicle for building Canadian-controlled corporate holdings.

  Source

• Adopt a public-private Canadian ownership modelStrategy

  Background

  The corporation was created in response to concerns about foreign ownership and the limited presence of Canadian-controlled companies in important sectors.

  Action taken

  The CDC combined federal participation with private investment and pursued profitable ownership positions in strategically important Canadian businesses.

  Aftermath

  The model attracted approximately 31,000 private shareholders and produced a diversified portfolio spanning resources, petrochemicals, healthcare, and industry.

  Source

1. 1Canada Development Corporationen.wikipedia.org
2. 2Marshall Crowe interview, Distinguished Canadianscbc.ca